Digitize Pharma Lifecycle Management For Faster Regulatory Filing

By David Brick, Senior Director, Data Science, IDBS

Whether you are a start-up company, CDMO or a Big Pharma organization, understanding the drivers for reducing time to regulatory filings is important. All pharma and biotech companies already follow a standard cycle to get therapeutics to market, but a proactive lifecycle management approach entails actively laying out a plan for how your company will move up the digital AND process maturity curves over time. Improving digital workflows and cloud-based solutions can help your company address data challenges that are stifling progress.